---
figid: PMC9358267__jdapm-22-277-g001
pmcid: PMC9358267
image_filename: jdapm-22-277-g001.jpg
figure_link: /pmc/articles/PMC9358267/figure/F1/
number: Fig. 1
figure_title: Effect of treatment with LPS or co-treatment with DEX and LPS on cytotoxicity
  in WISH cells was measured by MTT assay. Values are presented as mean ± standard
  deviation (SD). All experiments were repeated three times. DEX, dexmedetomidine;
  LPS, lipopolysaccharide; MTT, 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide
caption: Effect of treatment with LPS or co-treatment with DEX and LPS on cytotoxicity
  in WISH cells was measured by MTT assay. Values are presented as mean ± standard
  deviation (SD). All experiments were repeated three times. DEX, dexmedetomidine;
  LPS, lipopolysaccharide; MTT, 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide.
article_title: Dexmedetomidine and LPS co-treatment attenuates inflammatory response
  on WISH cells via inhibition of p38/NF-κB signaling pathway.
citation: Tae-Sung Kim, et al. J Dent Anesth Pain Med. 2022 Aug;22(4):277-287.
year: '2022'

doi: 10.17245/jdapm.2022.22.4.277
journal_title: Journal of Dental Anesthesia and Pain Medicine
journal_nlm_ta: J Dent Anesth Pain Med
publisher_name: The Korean Dental Society of Anesthsiology

keywords:
- Cyclooxygenase 2 Inhibitors
- Dexmedetomidine
- Lipopolysaccharides
- Prostaglandin E2
- WISH Cells

---
